|
1
|
Zeisel MB, Lucifora J, Mason WS, Sureau C,
Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, et
al: Towards an HBV cure: State-of-the-art and unresolved questions
- report of the ANRS workshop on HBV cure. Gut. 64:1314–1326. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
MacLachlan JH and Cowie BC: Hepatitis B
virus epidemiology. Cold Spring Harb Perspect Med. 5:a0214102015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roberts H, Kruszon-Moran D, Ly KN, Hughes
E, Iqbal K, Jiles RB and Holmberg SD: Prevalence of chronic
hepatitis B virus (HBV) infection in U.S. households: National
Health and Nutrition Examination Survey (NHANES), 1988–2012.
Hepatology. 63:388–397. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reddy KR, Bourlière M, Sulkowski M, Omata
M, Zeuzem S, Feld JJ, Lawitz E, Marcellin P, Welzel TM, Hyland R,
et al: Ledipasvir and sofosbuvir in patients with genotype 1
hepatitis C virus infection and compensated cirrhosis: An
integrated safety and efficacy analysis. Hepatology. 62:79–86.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamb C and Arbuthnot P: Activating the
innate immune response to counter chronic hepatitis B virus
infection. Expert Opin Biol Ther. 16:1517–1527. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jakubowska K, Pryczynicz A, Iwanowicz P,
Niewiński A, Maciorkowska E, Hapanowicz J, Jagodzińska D, Kemona A
and Guzińska-Ustymowicz K: Expressions of matrix metalloproteinases
(MMP-2, MMP-7, and MMP-9) and their inhibitors (TIMP-1, TIMP-2) in
inflammatory bowel diseases. Gastroenterol Res Pract.
2016:24561792016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nguyen K, Pan C, Xia V, Hu J and Hu KQ:
Clinical course of chronic hepatitis B (CHB) presented with normal
ALT in Asian American patients. J Viral Hepat. 22:809–816. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bae CB, Kim SS, Ahn SJ, Cho HJ, Kim SR,
Park SY, Song GW, Kim DJ, Hwang SG, Yang JM, et al: Caspase-cleaved
fragments of cytokeratin-18 as a marker of inflammatory activity in
chronic hepatitis B virus infection. J Clin Virol. 58:641–646.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Himaja N and Shama SN: Herbal wealth for
hepatotoxicity: A review. ASIA J Pharm Sci. 8:3–9. 2015.
|
|
10
|
Price J: An update on hepatitis B, D, and
E viruses. Top Antivir Med. 21:157–163. 2014.PubMed/NCBI
|
|
11
|
Ofliver KA: Korean Association for the
Study of the Liver: KASL Clinical Practice Guidelines: Management
of chronic hepatitis B. Clin Mol Hepatol. 18:109–162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karev VE: Fas, FasL, and bcl-2 expression
on hepatic intralobar lymphocytes in different variants of the
natural course of chronic HBV and HCV infection and in its
outcomes. Arkh Patol. 76:16–21. 2014.(In Russian). PubMed/NCBI
|
|
13
|
Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin
CL, Su TH, Tseng TC, Lin HH, Wang CC and Kao JH: HBV-DNA level at 6
months of entecavir treatment predicts HBeAg loss in HBeAg-positive
chronic hepatitis B patients. J Formos Med Assoc. 114:308–313.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsamandas AC, Thomopoulos K, Zolota V,
Kourelis T, Karatzas T, Ravazoula P, Tepetes K, Petsas T, Karavias
D, Karatza C, et al: Potential role of bcl-2 and bax mRNA and
protein expression in chronic hepatitis type B and C: A
clinicopathologic study. Mod Pathol. 16:1273–1288. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Coffin CS, Osiowy C, Gao S, Nishikawa S,
van der Meer F and van Marle G: Hepatitis B virus (HBV) variants
fluctuate in paired plasma and peripheral blood mononuclear cells
among patient cohorts during different chronic hepatitis B (CHB)
disease phases. J Viral Hepat. 22:416–426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aoudjit F, Estève PO, Desrosiers M,
Potworowski EF and St-Pierre Y: Gelatinase B (MMP-9) production and
expression by stromal cells in the normal and adult thymus and
experimental thymic lymphoma. Int J Cancer. 71:71–78. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Xu W, Chen Y, Xie X, Zhang Y, Ma
C, Yang Q, Han Y, Zhu C, Xiong Y, et al: MMP-9 facilitates
hepatitis B virus replication through binding with IFNAR1 to
repress IFN/JAK/STAT signaling. J Virol. 91:e01824–16. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao ZH, Fan YC, Zhao Q, Dou CY, Ji XF,
Zhao J, Gao S, Li XY and Wang K: Promoter methylation status and
expression of PPAR-γ gene are associated with prognosis of
acute-on-chronic hepatitis B liver failure. Clin Epigenetics.
7:1152015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Simone V, Franzè E, Ronchetti G,
Colantoni A, Fantini MC, Di Fusco D, Sica GS, Sileri P, MacDonald
TT, Pallone F, et al: Th17-type cytokines, IL-6 and TNF-α
synergistically activate STAT3 and NF-κB to promote colorectal
cancer cell growth. Oncogene. 34:3493–3503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Somal A, Aggarwal A and Upadhyay RC:
Effect of thermal stress on expression profile of apoptosis related
genes in peripheral blood mononuclear cells of transition Sahiwal
cow. Iran J Vet Res. 16:137–143. 2015.PubMed/NCBI
|
